Literature DB >> 11882585

Pressure promotes angiotensin II--mediated migration of human coronary smooth muscle cells through increase in oxidative stress.

Kenichi Yasunari1, Kensaku Maeda, Munehiro Nakamura, Junichi Yoshikawa.   

Abstract

Angiotensin II--mediated oxidative stress may play a role in the pathogenesis of coronary atherosclerosis. We examined the effects of pressure on the angiotensin II--mediated increase in oxidative stress and migration of cultured human coronary smooth muscle cells (SMCs). Increased pressure (100 mm Hg) by helium gas for 48 hours increased angiotensin II--mediated oxidative stress as evaluated by flow cytometry and SMC migration (from 15.9 +/- 2.2 to 32.0 +/- 2.4 cells per 4 high-power fields, P<0.05; n=8). The pressure-induced increases in oxidative stress observed appear to involve phospholipase D (PLD) and protein kinase C (PKC), inasmuch as the indirect PLD inhibitor suramin, at 100 micromol/L, and the PKC inhibitor chelerythrine, at 1 micromol/L, completely blocked the increase in angiotensin II--mediated oxidative stress induced by pressure. Pressure-induced increase in angiotensin II--mediated oxidative stress was inhibited by diphenylene iodonium chloride, an NADPH oxidase inhibitor, by 79% (P<0.05, n=8). Losartan (1 micromol/L), its active metabolite E3174 (1 micromol/L), and the antioxidant N-acetylcysteine (100 mmol/L) but not PD123319 (1 micromol/L) also blocked pressure-induced increases in angiotensin II--mediated oxidative stress and SMC migration (P<0.05, n=8). These findings suggest a novel cellular mechanism whereby pressure regulates the angiotensin II--mediated migration of SMCs, possibly via angiotensin II type 1 receptors, and which involves PLD-mediated, PKC-mediated, and NADPH oxidase--mediated increases in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882585     DOI: 10.1161/hy02t2.102991

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  N-terminal kinase, and c-Src are activated in human aortic smooth muscle cells by pressure stress.

Authors:  Noriteru Morita; Kenji Iizuka; Takeshi Murakami; Hideaki Kawaguchi
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

Review 2.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

3.  Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction.

Authors:  N Khaper; K Kaur; T Li; F Farahmand; P K Singal
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

4.  Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide.

Authors:  Qinghua Zeng; Qingwei Zhou; Fanrong Yao; Stephen T O'Rourke; Chengwen Sun
Journal:  J Pharmacol Exp Ther       Date:  2008-06-06       Impact factor: 4.030

5.  Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  Surgery       Date:  2008-05-27       Impact factor: 3.982

6.  Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis.

Authors:  Cheng-yang Li; Yao-liang Deng; Bing-hua Sun
Journal:  Int Urol Nephrol       Date:  2009-02-25       Impact factor: 2.370

Review 7.  Redox signaling, vascular function, and hypertension.

Authors:  Moo Yeol Lee; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

8.  Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.

Authors:  Andreas Goette; Alicja Bukowska; Christopher H Lillig; Uwe Lendeckel
Journal:  Front Physiol       Date:  2012-07-05       Impact factor: 4.566

Review 9.  Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.

Authors:  Andreas Goette; Uwe Lendeckel
Journal:  Cells       Date:  2021-09-30       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.